MediFind
Condition

Giant Cell Arteritis

Latest Research

Latest Advance
Study
  • Condition: Rheumatic Disease
  • Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
  • Treatment Used: Corticosteroid Tapering Regimens
  • Number of Patients: 62
  • Published —
This review of the literature assessed clinical outcomes of differing tapering regimens after corticosteroid monotherapy in adults with rheumatic disorders.
Latest Advance
Study
  • Condition: Aortitis Disease
  • Journal: The heart surgery forum
  • Treatment Used: Aortic Valve Surgery
  • Number of Patients: 15
  • Published —
The study researched the outcomes of aortic valve surgery in patients with aortitis disease.
Latest Advance
Study
  • Condition: Glucocorticoid Resistant Refractory Giant Cell Arteritis
  • Journal: BMJ case reports
  • Treatment Used: intravenous tocilizumab
  • Number of Patients: 1
  • Published —
The purpose of the study was to report a case of a patient with glucocorticoid resistant refractory giant cell arteritis treated with intravenous tocilizumab.
Latest Advance
Study
  • Condition: Large-vessel vasculitis giant cell arteritis (GCA) and Takayasu arteritis (TA)
  • Journal: Der Internist
  • Treatment Used: Tocilizumab (TCZ)
  • Number of Patients: 0
  • Published —
This study described the necessary diagnostic testing and rapid treatment approaches for patients diagnosed with large-vessel vasculitis -- giant cell arteritis (GCA) and Takayasu arteritis (TA) --
Latest Advance
Study
  • Condition: Scleritis
  • Journal: Ocular immunology and inflammation
  • Treatment Used: Tocilizumab
  • Number of Patients: 1
  • Published —
This case report discusses a 62-year-old Caucasian female diagnosed with scleritis and giant cell arteritis (GCA) treated with topical and systemic NSAIDs, prednisone and diverse disease-modifying antirheumatic drugs and tocilizumab.
Latest Advance
Study
  • Condition: Giant Cell Arteritis
  • Journal: International journal of rheumatic diseases
  • Treatment Used: Glucocorticoid Therapy
  • Number of Patients: 14
  • Published —
This study tested the safety and efficacy of using glucocorticoid therapy to treat patients with giant cell arteritis.
Latest Advance
Study
  • Condition: Giant Cell Arteritis
  • Journal: Rheumatology (Oxford, England)
  • Treatment Used: Tocilizumab Therapy
  • Number of Patients: 20
  • Published —
This study evaluated the incidence of relapse after discontinuing tocilizumab therapy in patients with giant cell arteritis (inflammation of the lining of the arteries).
Latest Advance
Study
  • Condition: Giant Cell Arteritis
  • Journal: Seminars in arthritis and rheumatism
  • Treatment Used: Tocilizumab
  • Number of Patients: 134
  • Published —
This study tested the safety and efficacy of using tocilizumab to treat patients with giant cell arteritis.
Latest Advance
Study
  • Condition: Subcutaneous Fluid Collection after Bentall Procedure in Female Patient with Giant Cell Arteritis
  • Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • Treatment Used: Immunosuppressive Therapy
  • Number of Patients: 1
  • Published —
This case report discusses a 61-year-old woman with giant cell arteritis who developed a subcutaneous fluid collection after the Bentall procedure.
Latest Advance
Study
  • Condition: Giant Cell Arteritis
  • Journal: Clinical rheumatology
  • Treatment Used: Leflunomide
  • Number of Patients: 76
  • Published —
This study evaluated the effectiveness of leflunomide (anti-rheumatic drug) in patients with Giant Cell Arteritis (GCA; inflammatory condition that affects the blood vessels).
Latest Advance
Study
  • Condition: Giant cell arteritis
  • Journal: European journal of internal medicine
  • Treatment Used: Tocilizumab as an add-on therapy to glucocorticoids
  • Number of Patients: 20
  • Published —
This study evaluated the effects of tocilizumab as an add-on therapy to glucocorticoids during the first three months of treatment for giant cell arteritis.
Latest Advance
Study
  • Condition: Refractory Giant Cell Arteritis
  • Journal: Seminars in arthritis and rheumatism
  • Treatment Used: Ustekinumab
  • Number of Patients: 25
  • Published —
This study tested the safety and efficacy of using ustekinumab to treat patients with refractory giant cell arteritis.